LRMR

Larimar Therapeutics (LRMR)

About Larimar Therapeutics (LRMR)

Larimar Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing treatments for patients suffering from complex rare diseases using a novel cell penetrating peptide technology platform. It also engages in the research, development, and commercialization of novel therapeutics for mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Details

Daily high

$4.67

Daily low

$4.47

Price at open

$4.59

52 Week High

$6.42

52 Week Low

$1.61

Market cap

494.2M

Dividend yield

0.00%

Volume

1.9M

Avg. volume

10.4M

P/E ratio

-2.12

Larimar Therapeutics News